Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Brown

Showing results (221-230 of 247) with videos related to

Pageof 25
Sort By:
BMC Veterinary Research|November 9, 2017
Letter to the editor - round table unites to tackle culture change in an effort to improve animal research reportingNicola J Osborne, Merel Ritskes-Hoitinga, Amrita Ahluwahlia, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2010
Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonistsBrian S Lucas, Wade Aaron, Songzhu An, et al.
OTA International : the Open Access Journal of Orthopaedic Trauma|April 24, 2025
High rate of complications after operative fixation of open periprosthetic distal femur fracturesYu Min Suh, Robert Bardsley, John Hwang, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slicesMatthew W Becker, Matthew Brown, Katherine Wiseman, et al.
Journal of Cannabis Research|July 3, 2021
Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi processArun Bhaskar, Alan Bell, Michael Boivin, et al.
Journal of Medicinal Chemistry|June 18, 2024
Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M<sub>4</sub> Muscarinic Acetylcholine ReceptorChristopher R Butler, Michael Popiolek, Laura A McAllister, et al.
The Journal of Pathology|April 1, 2018
Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune responseDaniel Temko, Inge C Van Gool, Emily Rayner, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AMG 853, a CRTH2 and DP Dual AntagonistJiwen Liu, An-Rong Li, Yingcai Wang, et al.
Journal of Medicinal Chemistry|August 11, 2012
Discovery and in vivo evaluation of dual PI3Kβ/δ inhibitorsFelix Gonzalez-Lopez de Turiso, Youngsook Shin, Matthew Brown, et al.
Neuro-Oncology|April 5, 2022
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumorsBenjamin M Ellingson, Elizabeth R Gerstner, Andrew B Lassman, et al.
Pageof 25

Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
BMC Veterinary Research|November 9, 2017
Letter to the editor - round table unites to tackle culture change in an effort to improve animal research reportingNicola J Osborne, Merel Ritskes-Hoitinga, Amrita Ahluwahlia, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2010
Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonistsBrian S Lucas, Wade Aaron, Songzhu An, et al.
OTA International : the Open Access Journal of Orthopaedic Trauma|April 24, 2025
High rate of complications after operative fixation of open periprosthetic distal femur fracturesYu Min Suh, Robert Bardsley, John Hwang, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slicesMatthew W Becker, Matthew Brown, Katherine Wiseman, et al.
Journal of Cannabis Research|July 3, 2021
Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi processArun Bhaskar, Alan Bell, Michael Boivin, et al.
Journal of Medicinal Chemistry|June 18, 2024
Design and Synthesis of Clinical Candidate PF-06852231 (CVL-231): A Brain Penetrant, Selective, Positive Allosteric Modulator of the M<sub>4</sub> Muscarinic Acetylcholine ReceptorChristopher R Butler, Michael Popiolek, Laura A McAllister, et al.
The Journal of Pathology|April 1, 2018
Somatic POLE exonuclease domain mutations are early events in sporadic endometrial and colorectal carcinogenesis, determining driver mutational landscape, clonal neoantigen burden and immune responseDaniel Temko, Inge C Van Gool, Emily Rayner, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of AMG 853, a CRTH2 and DP Dual AntagonistJiwen Liu, An-Rong Li, Yingcai Wang, et al.
Journal of Medicinal Chemistry|August 11, 2012
Discovery and in vivo evaluation of dual PI3Kβ/δ inhibitorsFelix Gonzalez-Lopez de Turiso, Youngsook Shin, Matthew Brown, et al.
Neuro-Oncology|April 5, 2022
Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumorsBenjamin M Ellingson, Elizabeth R Gerstner, Andrew B Lassman, et al.
Pageof 25